Chr. Hansen completes its US$939m sale of Natural Colors business

DENMARK – Global biosciences company Chr. Hansen has completed the sale of its Natural colours business to global investment organization EQT in line with its 2025 strategy of focusing on microbial and fermentation technology platforms. The divestment covers business operations with asset transfers in more than 30 countries including the transfer of five separate corporate entities and around 600 employees. According to a FoodIngredientsFirst report, the Danish-based company had agreed to sell its business to EQT in September 2020 for US$939 million on a cash and debt-free basis. The company…

Read More

Chr. Hansen Natural Colors appoints Barentz as its strategic distribution partner in Southern Africa

SOUTHERN AFRICA – Chr. Hansen Natural Colors, the world leader in food colouring solutions developed from natural sources, has appointed Barentz as its strategic partner for the distribution of its product portfolio in South Africa and Zimbabwe. Barentz is a global life science ingredients distributor for the human nutrition, pharmaceutical, personal care and animal nutrition markets. The appointment is an extension of an exciting partnership between the two companies and gives Barentz’ customers in the two Southern African countries access to the largest and most vibrant colour portfolio in human…

Read More

Food ingredient company Chr. Hansen unveils FreshQ DA, a bioprotection solution for fermented plant-based products

DENMARK – Global bioscience company Chr. Hansen has expanded its FreshQ line with the launch of FreshQ DA, a bioprotection solution designed for fermented plant-based products. According to Chr. Hansen, FreshQ DA is a food culture that helps strengthen fermentation of plant-based products, providing better protection against spoilage caused by yeasts and moulds. As well as keeping foods safe and fresh for longer, Chr. Hansen says that its FreshQ solution can help manufacturers meet demand for food with fewer artificial ingredients. It further notes that extending freshness can also help…

Read More

Chr. Hansen records a 5% organic growth for fiscal year 2019/20 driven by strong growth in enzymes

DENMARK – Chr. Hansen has published its full-year statement of results 2019/20 which shows a 5% organic growth for fiscal year 2019/20 sitting in the middle of its 4-6% guidance a revenue increase of 2 percent to €1.189 billion (US$1.4 billion). According to the company, the organic growth was primarily driven by strong growth in enzymes and continued solid growth in core categories such as cheese and meat cultures, and good growth in fermented milk. In enzymes, growth was driven by the launch of CHY-MAX Supreme and by the continued…

Read More

Chr. Hansen acquires HMO manufacturer Jennewein Biotechnologie for US$363m

GERMANY – Chr. Hansen, global bioscience company that develops natural ingredient solutions, has signed an agreement to acquire Jennewein Biotechnologie, a manufacturer of rare functional sugars, for a total consideration of €310 million (US$363.6m), entering the human milk oligosaccharides (HMO). The deal includes all the shares of the international industrial biotechnology company and is in line with Chr. Hansen’s 2025 strategy of pursuing acquisitions that extend and strengthen its microbial and fermentation technology platforms. Upon completion of the transaction, which is expected later this month, Jennewein will transfer into the…

Read More

Bioscience company Chr. Hansen launches new culture for creation of pizza cheeses

DENMARK – Chr. Hansen, bioscience company, has launched a new culture for the creation of pizza cheeses, which it claims can reduce the degree of browning by up to 100%. The F-DVS Pure Appeal culture is launching worldwide and is said to also help protect the cheese from yeast and mould spoilage in the supply chain, ensuring product quality and safety. People all over the world love pizza, and the ever-increasing demand is accelerating the production of pasta filata, which is the largest, fastest growing segment and most globally widespread cheese type,…

Read More

Bioscience company Chr. Hansen focuses on microbial science in 2025 strategy

DENMARK – Chr. Hansen, a global bioscience company, has announced that it aims to strengthen and focus its activities on microbial science to improve food and health for a sustainable future, as part of its 2025 strategy.  Over the last 30 years, Chr. Hansen has built a microbial business for animal feed, dietary supplements and infant formula. Going forward, the ingredients firm says it will continue to focus investments on its microbial and fermentation technology platforms, putting its food cultures & enzymes and health & nutrition divisions at the centre of its new…

Read More

Chr. Hansen Holding appoints Lise Skaarup Mortensen as new CFO

DENMARK – Chr. Hansen Holding, a global bio science company, has appointed Lise Skaarup Mortensen as new Chief Financial Officer (CFO). Lise is an experienced international leader with a strong track-record and a passion for leadership who joins from a position as CFO at Microsoft Germany. Lise will start at Chr. Hansen on October 1, 2020, after which there will be a short transition period until current CFO Søren Westh Lonning leaves, expected by the end of October. Lise will join the Executive Board after the transition period is completed. “I am very…

Read More

Chr. Hansen secures green energy supply deal to power sustainability ambitions

DENMARK – Global bioscience company, Chr. Hansen has signed a 10-year agreement Power Purchase Agreement (PPA) with Danish company, Better Energy to power Chr. Hansen’s Denmark operations with green electricity. Under the agreement, Better Energy Denmark will supply green energy to the ingredients supplier from two brand new solar parks that have just been taken into operation. Chr. Hansen further noted that Energy Denmark will also support the agreement by being responsible for creating a balance between consumption and production of electricity and handling the difference that will always exist…

Read More

Chr. Hansen acquires HSO Health Care to grow its women probiotics offering

DENMARK – The Danish biosciences company, Chr. Hansen has entered into an agreement to acquire Austria-based B2B company specializing in probiotics for women’s health, HSO Health Care GmbH. The companies did not disclose the details of the transaction. However, Chr. Hansen said that the acquisition will be financed from existing available cash and bank facilities adding that it has no impact on its the 2019/20 outlook. The transaction is expected to close later this week. Chr Hansen also expects HSO’s 2020 revenues to hit approximately EUR15 million, with an EBITDA…

Read More